ACI
MDCO

AMP Capital Investors’s Medicines Co MDCO Stock Holding History

AMP Capital Investors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,449
Closed -$236K – 1281
2014
Q1 		$236K Hold
8,449
– – ﹤0.01% 1092
2013
Q4 		$326K Hold
8,449
– – ﹤0.01% 1074
2013
Q3 		$287K Buy
+8,449
New +$269K ﹤0.01% 1064

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

AMP Capital Investors's MDCO Position: Q2 2014 in Review

AMP Capital Investors sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 8,449 shares — an estimated $236K sold.

AMP Capital Investors first reported a position in MDCO in Q3 2013 and held it in 3 quarters. The position peaked at $326K in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • AMP Capital Investors reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • AMP Capital Investors sold 8,449 Medicines Co shares in Q2 2014, an estimated $236K.
  • AMP Capital Investors first reported a position in Medicines Co in Q3 2013 and held it in 3 quarters.
  • AMP Capital Investors's Medicines Co position peaked at $326K in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on AMP Capital Investors's 13F filing for Q2 2014, filed 14 Aug 2014.